Cargando…

Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?

Detalles Bibliográficos
Autores principales:	Park, Jihye, Cheon, Jae Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association for the Study of Intestinal Diseases 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478752/ https://www.ncbi.nlm.nih.gov/pubmed/28670224 http://dx.doi.org/10.5217/ir.2017.15.3.263

Ejemplares similares

Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet’s Disease
por: Park, Jihye, et al.
Publicado: (2018)

Efficacy and tolerability of methotrexate therapy for refractory intestinal Behçet's disease: a single center experience
por: Park, Jihye, et al.
Publicado: (2018)

Efficacy of Adalimumab in a Girl with Refractory Intestinal Behcet's Disease
por: Kaji, Mariko, et al.
Publicado: (2015)

Outcome Predictors for Intestinal Behçet's Disease
por: Park, Jae Jun, et al.
Publicado: (2013)

Updated treatment strategies for intestinal Behçet’s disease
por: Park, Yong Eun, et al.
Publicado: (2018)

Adalimumab in Vogt-Koyanagi-Harada Disease Refractory to Conventional Therapy
por: Yang, Shizhao, et al.
Publicado: (2022)

Adalimumab in the management of Behçet’s disease
por: Ueda, Atsuhisa, et al.
Publicado: (2015)

Risk Factors for Surgery in Patients with Intestinal Behçet’s Disease During Anti-Tumor Necrosis Factor-Alpha Therapy
por: Han, So Jung, et al.
Publicado: (2023)

Adalimumab plus Conventional Therapy versus Conventional Therapy in Refractory Non-Infectious Scleritis
por: Chen, Binyao, et al.
Publicado: (2022)

Optimal diagnosis and disease activity monitoring of intestinal Behçet's disease
por: Lee, Hyun Jung, et al.
Publicado: (2017)

Behçet's disease-induced massive small intestinal bleeding successfully treated with adalimumab
por: Liu, PH, et al.
Publicado: (2023)

Advances in Management of Intestinal Behçet’s Disease: A Perspective From Gastroenterologists
por: Cheon, Jae Hee
Publicado: (2021)

Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis
por: Kim, Jae Hyun, et al.
Publicado: (2016)

Pulmonary Sarcoidosis in Behçet’s Disease Treated with Adalimumab
por: Louro, Marlene, et al.
Publicado: (2017)

Tofacitinib as an alternative therapy for refractory intestinal Behçet’s syndrome
por: Zou, Jun, et al.
Publicado: (2022)

Long-Term Efficacy of Adalimumab in Patients With Intestinal Behcet’s Disease: Eight Consecutive Cases
por: Tanida, Satoshi, et al.
Publicado: (2016)

Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?
por: Kim, Duk Hwan, et al.
Publicado: (2016)

Usefulness of Adalimumab for Treating a Case of Intestinal Behçet's Disease With Trisomy 8 Myelodysplastic Syndrome
por: Kimura, Masamichi, et al.
Publicado: (2015)

Proteomic analysis-based discovery of a novel biomarker that differentiates intestinal Behçet’s disease from Crohn’s disease
por: Park, Jihye, et al.
Publicado: (2021)

Successful closure of ileostomy in a patient with intestinal Behçet's disease after therapy with adalimumab: A case report
por: Yan, Zhe, et al.
Publicado: (2019)

Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α
por: Park, Jihye, et al.
Publicado: (2022)

Real-world effectiveness and safety of adalimumab in Korean patients with intestinal Behcet’s disease: a Korean Association for the Study of Intestinal Diseases (KASID) multicenter study
por: Lee, Seung Bum, et al.
Publicado: (2023)

Cancer Risk in Patients with Intestinal Behçet’s Disease: A Nationwide Population-Based Study
por: Han, Minkyung, et al.
Publicado: (2018)

Early administration of adalimumab for paediatric uveitis due to Behçet’s disease
por: Hiyama, Tomona, et al.
Publicado: (2019)

Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?
por: Park, Jihye, et al.
Publicado: (2021)

Identification of genetic susceptibility loci for intestinal Behçet’s disease
por: Kim, Seung Won, et al.
Publicado: (2017)

C-reactive protein is associated with postoperative outcomes in patients with intestinal Behçet’s disease
por: Kang, Eun Ae, et al.
Publicado: (2021)

Radiation Exposure from Abdominal Imaging Studies in Patients with Intestinal Behçet Disease
por: Jung, Yoon Suk, et al.
Publicado: (2014)

Adalimumab in Treatment of Uveitis in Pediatric Behcet’s Disease–a Case Report
por: Halilbasic, Meliha, et al.
Publicado: (2021)

Development of a Novel Endoscopic Scoring System to Predict Relapse after Surgery in Intestinal Behçet’s Disease
por: Park, Jung Won, et al.
Publicado: (2018)

Overlooked Management and Risk Factors for Anemia in Patients with Intestinal Behçet’s Disease in Actual Clinical Practice
por: Kim, Bun, et al.
Publicado: (2015)

The Efficacy of Adalimumab as an Initial Treatment in Patients with Behçet’s Retinal Vasculitis
por: Yang, Shizhao, et al.
Publicado: (2021)

Adalimumab Therapy Improves Intestinal Dysbiosis in Crohn’s Disease
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2019)

The Effect of Adalimumab in Korean Patients with Refractory Noninfectious Uveitis
por: Park, Sung Eun, et al.
Publicado: (2021)

Interplay between chronic inflammation and clonal haematopoiesis of indeterminate potential in Behçet’s disease
por: Park, Jihye, et al.
Publicado: (2023)

Experience of using adalimumab in treating sight-threatening paediatric or adolescent Behcet’s disease-related uveitis
por: Ho, Mary, et al.
Publicado: (2019)

Possible Association of Mutations in the MEFV Gene with the Intestinal Phenotype of Behçet’s Disease and Refractoriness to Treatment
por: Furuta, Yoki, et al.
Publicado: (2023)

Serum KL-6 elevation in a uveitis patient with Behçet's disease treated with adalimumab
por: Ono, Takashi, et al.
Publicado: (2020)

Long-term safety and efficacy of adalimumab for intestinal Behçet's disease in the open label study following a phase 3 clinical trial
por: Inoue, Nagamu, et al.
Publicado: (2017)

Intestinal Perforations in Behçet’s Disease
por: Chou, Shao-Jiun, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_m56sd0uh66stqb3thppnet39n8